Target intelligence / Profile preview

Ribosomal protein L7a pseudogene 79 (RPL7AP79)

Target
RPL7AP79
Molecular classification
Other (Pseudogene)
01

Overview

RPL7AP79 (ribosomal protein L7a pseudogene 79) is a processed pseudogene derived from the RPL7A gene, which encodes the 60S ribosomal protein L7a, a component of the large ribosomal subunit involved in protein synthesis[1][2][5][7]. Pseudogenes like RPL7AP79 are non-functional genomic DNA sequences similar to functional genes but typically lack the regulatory elements required for expression and do not encode functional proteins[6][8]. Processed pseudogenes arise when RNA transcripts from protein-coding genes are reverse-transcribed and integrated into new locations in the genome, lacking introns and regulatory promoters[6][8]. While most pseudogenes are considered non-functional, some may have regulatory roles at the RNA level, but there is no specific evidence for regulatory or disease relevance for RPL7AP79[6]. Key points: - RPL7AP79 is a non-coding processed pseudogene. - It is not a protein, enzyme, receptor, transporter, or drug target. - No functional protein or receptor is produced from this locus. - There is no association with known drugs, disease mechanisms, or use as a biomarker. - If you were seeking information on an active ribosomal protein target, the correct term is "ribosomal protein L7a" (RPL7A), not this pseudogene[3][5].

Other names
RPL7AP79ribosomal protein L7a pseudogene 79
02

Biological functions

Other (Processed pseudogenes generally lack intrinsic biological function, though some pseudogenes may regulate their parental gene at the RNA level in special cases.)
03

Disease associations

Other (No direct disease association for RPL7AP79; however, pseudogenes in general can participate in regulatory networks or be deregulated in diseases such as cancer, but no evidence directly links RPL7AP79 to any disease.)

Beyond the preview

Go deeper on Ribosomal protein L7a pseudogene 79 (RPL7AP79).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L7a pseudogene 79 (RPL7AP79).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call